Prolonged exposure to proton pump inhibitors (PPI) at the time of initiation of immune checkpoint blockade (ICB) mediates better clinical outcomes in patients with metastatic melanoma

KS Shohdy, Y Hatahet, T Gillham, ETT Yacoub, A Gupta, F Gomes, F Thistlethwaite, F Blackhall, P Lorigan, N Cook

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)S693-S693
Number of pages1
JournalAnnals of Oncology
Volume34
DOIs
Publication statusPublished - 1 Oct 2023

Cite this